APA (7th ed.) Citation

Jiapeng Li, Shuhan Liu, Jian Shi, & Hao-Jie Zhu. (2021). Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection. MDPI AG.

Chicago Style (17th ed.) Citation

Jiapeng Li, Shuhan Liu, Jian Shi, and Hao-Jie Zhu. Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection. MDPI AG, 2021.

MLA (9th ed.) Citation

Jiapeng Li, et al. Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection. MDPI AG, 2021.